Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024
Briefly

Alphatec stock, having plummeted by 92% since its 2022 IPO, has analysts surmising that it represents a profound buying opportunity with significant upside potential.
Despite ending 2023 with a gain similar to that of the S&P 500, Alphatec shares have sunk to multi-year lows, raising questions about a potential rebound.
Read at 24/7 Wall St.
[
|
]